Back to top
more

Walgreens Boots Alliance (WBA)

(Real Time Quote from BATS)

$9.54 USD

9.54
10,500,699

+0.47 (5.18%)

Updated Nov 11, 2024 01:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 10% (225 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Urmimala Biswas headshot

CVS Stock Tanks 27.5% Year to Date: Time to Buy the Dip?

by Urmimala Biswas

While CVS Health has been grappling with pharmacy reimbursement pressure, a turnaround might be in the cards, given its several strategic initiatives.

Walgreens Boots Alliance (WBA) Rises As Market Takes a Dip: Key Facts

by Zacks Equity Research

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $10.38, marking a +0.78% move from the previous day.

Walgreens (WBA) Partners With BARDA to Boost Clinical Research

by Zacks Equity Research

Walgreens (WBA) and BARDA form a strategic partnership to bolster the decentralized clinical trial model.

Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

Walgreens Boots Alliance (WBA) closed at $10.92 in the latest trading session, marking a +0.92% move from the prior day.

Interactive Brokers and Walgreens Boots Alliance have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Interactive Brokers and Walgreens Boots Alliance are part of the Zacks Bull and Bear of the Day article.

Derek Lewis headshot

Bear of the Day: Walgreens Boots Alliance (WBA)

by Derek Lewis

WBA has been a classic example of 'it can always go lower', with shares unable to find any traction over recent years.

The Zacks Analyst Blog CVS Health, Walgreens and Herbalife

by Zacks Equity Research

CVS Health, Walgreens and Herbalife are included in this Analyst Blog.

Urmimala Biswas headshot

What is the Right Approach for CVS Health (CVS) Post Q2 Results?

by Urmimala Biswas

The near-term challenges for CVS Health (CVS) are no doubt worrisome. Yet, the company remains focused on its strategic moves, utilizing integrated healthcare models and technological advancements.

Company News for Aug 6, 2024

by Zacks Equity Research

Companies In The Article Are:CG, WBA, K and TSN

Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Walgreens (WBA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Urmimala Biswas headshot

CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?

by Urmimala Biswas

CVS Health (CVS) is grappling with a sudden increase in Medicare Advantage members' utilization trend. The Medicaid business, too, is expected to have experienced medical cost pressure in the second quarter.

Urmimala Biswas headshot

CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?

by Urmimala Biswas

While CVS Health (CVS) has been grappling with the pharmacy reimbursement pressure, a turnaround might be in the cards given its several strategic initiatives.

Super Micro Computer and Walgreens Boots Alliance have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Super Micro Computer and Walgreens Boots Alliance are part of the Zacks Bull and Bear of the Day article.

Derek Lewis headshot

Bear of the Day: Walgreens Boots Alliance (WBA)

by Derek Lewis

Margin pressures and lowered guidance paint a challenging picture for the company's shares in the near term.

Walgreens Boots (WBA) Q3 Earnings Miss, Gross Margin Down

by Zacks Equity Research

An increasingly challenging pharmacy industry and consumer environment hurt Walgreens Boots' (WBA) bottom line in the third quarter of fiscal 2024.

Nike and Walgreens Boot Alliance are part of Zacks Earnings Preview

by Zacks Equity Research

Nike and Walgreens Boot Alliance are highlights of Zacks Earnings Preview article.

Sheraz Mian headshot

Q2 Earnings Growth Forecasted to Hit Two-Year High

by Sheraz Mian

Q2's expected quarterly earnings growth pace of +8.3% reflects the strongest growth since back in Q1 of 2022. Tech is expected to do some heavy lifting again, with earnings expected to be up +15.5% on +9.5% higher revenues.

Sweta Killa headshot

Top and Flop ETFs of the First Half

by Sweta Killa

We have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024.

Cencora (COR) Stock Nosedives: Here's What Caused the Decline

by Zacks Equity Research

Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.

Initial Claims Lower-Than-Expected

by Zacks Equity Research

Initial Claims Lower-Than-Expected.

Mark Vickery headshot

Jobless Claims Up, Consumption Down; Walgreens Down Big

by Mark Vickery

New jobless claims shrank a tad, but longer-term came in the highest in 2 1/2 years.

Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings

by Zacks Equity Research

The headline numbers for Walgreens (WBA) give insight into how the company performed in the quarter ended May 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates

by Zacks Equity Research

Walgreens (WBA) delivered earnings and revenue surprises of -5.97% and 1.07%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Micron, Levi's Trade Down After Market on Earnings

by Mark Vickery

After finishing mostly in the green today, late trading has gotten harsh for MU and LEVI.

Exploring Analyst Estimates for Walgreens (WBA) Q3 Earnings, Beyond Revenue and EPS

by Zacks Equity Research

Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended May 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.